drugset / Trial / NCT00603772
Clinical Evaluation of the Photoallergy Potential of Atralin Gel
RandomizedSingle-groupSingle-blind
Summary
To assess the potential of tretinoin gel 0.05% and its vehicle to produce photoallergic reactions, measured as skin reactions following induction and challenge.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tretinoin | Small molecule | 0.05 % | — |
Indications
No indication recorded.